The BioPharma industry has a difficult balance to maintain between mitigating risk of a life and death nature and innovating to stay ahead of the curve and to develop life changing products for millions across the globe.
At the heart of this balance lies the Statistical Computing Environments which prove the efficacy and safety of all new drug applications to worldwide regulatory authorities. Our paper titled: The Future of Validated SCE, looks deeper into Validated SCEs and determines the next steps in the ongoing evolution.